319 related articles for article (PubMed ID: 35563031)
1. Antidiabetic Drugs in the Treatment of Alzheimer's Disease.
Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031
[TBL] [Abstract][Full Text] [Related]
2. [The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review].
Ishmuratova AN; Abramov MA; Kuznetsov KO; Ivanyuta MV; Shakirova ZF; Kitapova AI; Usmonov MD; Chernousova LM; Valeeva LI; Kuznetsova AY; Baislamov AS; Shaihetdinova AR; Mirgaliev AA; Orozberdiev ST; Yakupova KI
Probl Endokrinol (Mosk); 2023 Nov; 69(5):73-83. PubMed ID: 37968954
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones.
Cardoso S; Moreira PI
Int Rev Neurobiol; 2020; 155():37-64. PubMed ID: 32854858
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
[TBL] [Abstract][Full Text] [Related]
5. Diabetes drugs in the fight against Alzheimer's disease.
Boccardi V; Murasecco I; Mecocci P
Ageing Res Rev; 2019 Sep; 54():100936. PubMed ID: 31330313
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease.
Nowell J; Blunt E; Gupta D; Edison P
Ageing Res Rev; 2023 Aug; 89():101979. PubMed ID: 37328112
[TBL] [Abstract][Full Text] [Related]
7. Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Ali SK; Ali RH
PLoS One; 2022; 17(7):e0271138. PubMed ID: 35802659
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
[TBL] [Abstract][Full Text] [Related]
9. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment.
Li X; Song D; Leng SX
Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818
[TBL] [Abstract][Full Text] [Related]
10. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings.
Khezri MR; Yousefi K; Mahboubi N; Hodaei D; Ghasemnejad-Berenji M
Biochem Pharmacol; 2022 Mar; 197():114945. PubMed ID: 35134385
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between Alzheimer's disease and diabetes: a focus on anti-diabetic drugs.
Goodarzi G; Tehrani SS; Fana SE; Moradi-Sardareh H; Panahi G; Maniati M; Meshkani R
Metab Brain Dis; 2023 Aug; 38(6):1769-1800. PubMed ID: 37335453
[TBL] [Abstract][Full Text] [Related]
12. The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.
Watson GS; Craft S
CNS Drugs; 2003; 17(1):27-45. PubMed ID: 12467491
[TBL] [Abstract][Full Text] [Related]
13. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.
Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB
Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease.
Das S; Ramachandran AK; Halder D; Akbar S; Ahmed B; Joseph A
CNS Neurol Disord Drug Targets; 2023; 22(7):973-993. PubMed ID: 35770411
[TBL] [Abstract][Full Text] [Related]
15. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
[TBL] [Abstract][Full Text] [Related]
16. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
Pradhan SP; Sahu PK; Behera A
Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
[TBL] [Abstract][Full Text] [Related]
17. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin.
Lin HC; Chung CH; Chen LC; Wang JY; Chen CC; Huang KY; Tsai MH; Chien WC; Lin HA
Sci Rep; 2023 Apr; 13(1):6625. PubMed ID: 37095270
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Akter K; Lanza EA; Martin SA; Myronyuk N; Rua M; Raffa RB
Br J Clin Pharmacol; 2011 Mar; 71(3):365-76. PubMed ID: 21284695
[TBL] [Abstract][Full Text] [Related]
20. Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease.
Kazkayasi I; Telli G; Nemutlu E; Uma S
Life Sci; 2022 Jun; 299():120538. PubMed ID: 35395244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
